MacroGenics is a biopharmaceutical company that focuses on discovering and developing innovative antibody-based therapeutics for the treatment of cancer. Founded in 2000, MacroGenics has been at the forefront of advancing the field of immuno-oncology with a diverse pipeline of novel product candidates aimed at addressing unmet medical needs in oncology. The company's cutting-edge research and development efforts have positioned it as a leader in the development of next-generation cancer therapies.

Refer new talent to Macrogenics